Chengda Pharmaceutical (301201.SZ) shareholder Qianhai Shengtai plans to reduce its shareholding by no more than 3.23%.

Zhitong Finance APP news, Chengda Pharmaceutical (301201.SZ) announced that the company's shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) (referred to as "Qianhai Shengtai") plans to reduce its holdings of the company's shares through block trading within 3 months after 15 trading days from the date of this announcement (May 30, 2025 to August 29, 2025), with a maximum of 4.8949 million shares (3.23% of the total share capital of the company excluding the shares held in the buyback account).